President Juan Manuel Santos of Colombia has sanctioned a new bill which prohibits surgical aesthetic procedures for all under-18 children. The procedure will not be carried out even when parents have no objection. The aesthetic procedures are used to achieve greater facial and body features. In Colombia, a huge number of under-18 girls undergo aesthetic procedures. According to the President, these procedures can lead to irreversible results, which alter decisions of life and the full exercise of maternity or health conditions that may require more surgical procedures. The procedures have risks that young people cannot foresee at young age and it cannot be justified under the responsible exercise of parental authority. However, the ban does not apply to surgery nose, eyes & ears, bad reconstructive surgeries performed by doctors, mechanics & superficial chemical peels and laser hair removal. Nor does it apply to surgeries caused by physical or psychological pathologies duly accredited by the respective health professionals.
GHI Analysis
The leading source of MedTech market intelligence in Latin America. Verified data and competitor insights across the key markets in the region. At GHI, we turn hospital data into strategic actions. Our insights help healthcare companies expand by providing accurate, up-to-date information on hospital infrastructure in LATAM and Asia.
Related Posts
Análisis GHI
Latin America pharmaceutical sales to grow 12% per year through 2017
Latin America pharmaceutical sales to grow 12% per year through 2017
With pharmaceutical sales growing at 3% per year in mature markets such as North America,…
GHI Analysisoctubre 6, 2014
Análisis GHI
The Deadliest Diseases in Mexico
The Deadliest Diseases in Mexico
General trends the healthcare industry needs to focus on
GHI Analysisoctubre 31, 2018
News
Chile: Increased transparency amongst pharmaceutical industry stakeholders in Chile
Chile: Increased transparency amongst pharmaceutical industry stakeholders in Chile
The Medical College of Chile and Chamber of Pharmaceutical Innovation of Chile (CIF) signed an…
GHI Analysismayo 8, 2017